These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6127621)

  • 1. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):52-6. PubMed ID: 7132962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide.
    Wreggett KA; Seeman P
    Mol Pharmacol; 1984 Jan; 25(1):10-7. PubMed ID: 6231467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of typical and atypical neuroleptics on binding of [3H]spiroperidol in calf caudate.
    Lin CW; Maayani S; Wilk S
    J Pharmacol Exp Ther; 1980 Mar; 212(3):462-8. PubMed ID: 6102144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of in vitro serotonin on dopaminergic binding sites in rat striatal membranes].
    Oelssner W; Raubach KH; Oelssner W
    Biomed Biochim Acta; 1983; 42(7-8):931-6. PubMed ID: 6651809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
    Titeler M
    Biochem Pharmacol; 1981 Nov; 30(22):3031-7. PubMed ID: 7337719
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR; Watanabe M; Seeman P
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
    Sibley DR; Creese I
    Mol Pharmacol; 1983 May; 23(3):585-93. PubMed ID: 6223205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical modification reveals involvement of tyrosine in ligand binding to dopamine D1 and D2 receptors.
    Srivastava LK; Mishra RK
    Biochem Int; 1990; 21(4):705-14. PubMed ID: 2241996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
    Nakajima T; Iwata K
    Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland.
    Lin C; McGonigle P; Molinoff PB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):950-6. PubMed ID: 2958621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
    Andorn AC; Bacon BR; Nguyen-Hunh AT; Parlato SJ; Stitts JA
    Mol Pharmacol; 1988 Feb; 33(2):155-62. PubMed ID: 3340080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of antipsychotic drugs on dopamine-receptors on caudate calf].
    Guo QY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):296-9, 317-8. PubMed ID: 1363315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]Apomorphine binding to a GTP-sensitive dopaminergic site in bovine anterior pituitary gland.
    Di Paolo T; Gagné B; Poyet P; Labrie F
    Can J Biochem; 1982 Nov; 60(11):1043-9. PubMed ID: 7172091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of ligand binding to pituitary D-2 dopaminergic receptors. Effects of divalent cations and functional group modification.
    Sibley DR; Creese I
    J Biol Chem; 1983 Apr; 258(8):4957-65. PubMed ID: 6833284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptor binding in bovine intermediate lobe pituitary membranes.
    Sibley DR; Creese I
    Endocrinology; 1980 Nov; 107(5):1405-9. PubMed ID: 7428676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor.
    Battaglia G; Titeler M
    Eur J Pharmacol; 1982 Jul; 81(3):493-8. PubMed ID: 6126376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.